Dickinson, ND- June 17, 2010-Signal Butte recently published an article on Trial Runners, LLC in their Spring 2010 edition. Signal Butte is a published magazine from Dickinson State University.  The article, "The best of both worlds" by Kevin Holten can be seen by clicking on this link: Signal Butte Spring 2010.

If you want more information about Trial Runners, LLC please visit the website www.trialrunners.com or contact the company at info@trialrunners.com.

Dickinson, ND- May 17, 2010-City Magazine recently did an article on Trial Runners, LLC in their April 2010 edition.  The article, "From Midtown to Downtown" by Kevin Holten can be seen by clicking on this link: City Magazine April 2010. 

Trial Runners will attend ARVO in Support of the Advancement of Eye & Vision Research

Dickinson, ND- February 10, 2010-The Association for Research in Vision and Ophthalmology's (ARVO) 2010 Annual Meeting is an international gathering of eye and vision researchers. The goal is to explore this changing environment and its implications during the next decade and beyond, and Trial Runners will be there to support this effort! We will have a booth at the ARVO 2010 Annual Meeting, which will be in Fort Lauderdale, Florida from May 2 – 6, 2010. "The purposes of ARVO shall be to encourage and assist research, training, publication, and dissemination of knowledge in vision and ophthalmology." (Article 1.02 of the Bylaws) The 2010 ARVO Annual Meeting will highlight the latest innovative research and techniques through sessions and activities held throughout the week.

Dickinson, ND, December 16, 2009—Trial Runners, LLC is excited to announce the start of their non-profit Contract Research Organization (CRO) independent affiliate called TR Cares. The mission of TR Cares is to support drug and device development by providing clinical research expertise, which enables novel medications to reach the marketplace quickly, safely and effectively. TR Cares will collaborate with non-profit drug development entities (universities, hospitals etc) and advance their clinical research program by offering services (consulting, project management, data management, safety, medical writing and quality control) at little to no cost. The cost of the clinical research program will be supported by donation of time by independent clinical research professionals, donation of resources by contract research organizations, by community donation and by payment from the non-profit partner. “For those who believe that they have found a real treatment option but can’t afford to develop it, who cannot get enough interest from larger pharmaceutical companies to purchase their product, or get venture capitalists to invest in it, there is a solution-TR Cares.” stated Jill Healy, President of TR Cares.

TR Cares is an independent affiliate of Trial Runners, LLC. Trial Runners will act as a guide for TR Cares and will volunteer its space and resources in support of the non-profit affiliate. Currently, TR Cares is recognized as a company by the IRS and is expecting 501(c)3-status approval in the first quarter of 2010. TR Cares has a very in-depth board of directors who are committed to seeing the vision and mission of TR Cares fulfilled. Jill Healy, COO of Trial Runners, LLC is the President of the board. Aaron Ondrey, Treasurer of TR Cares, has extensive experience in pharmaceutical and biotech finance and was previously employed with both Jerini Ophthalmic and (OSI) Eyetech, Inc. Secretary of TR Cares, Yordak Salermo, is the Vice President of Global Development at Trial Runners, LLC and has widespread knowledge of global trial operations. Two other directors on the Board are Gayle Gironda and Denise Teuber. Gayle Gironda is the Executive Director, Talent Acquisition at Watson Pharmaceuticals and was formerly the Vice President, Business Ops & HR at Jerini AG - Jerini Ophthalmic, Inc. Gayle is very proficient in human resources and building a company’s infrastructure. Denise Teuber is the Sr. Study Manager at Ophthotech and has significant experience in supervision and administration of day-to-day operations in clinical trial management.

TR Cares is creating a partnership with an organization called Covalent Immunology Foundation (CIF). They are a non-profit organization working on an HIV vaccine. For more information concerning CIF and the partnership follow this link, Can This Man Cure AIDS? Collaborations with organizations like CIF, will allow TR Cares to influence not only the drug development industry but also the world.

If you have any immediate inquiries concerning TR Cares, please contact info@trialrunners.com for more information. Look for the launch of the TR Cares website in the first quarter of 2010.